Related Experiment Video
Updated: Feb 12, 2026

Identification of Metal Oxide Nanoparticles in Histological Samples by Enhanced Darkfield Microscopy and Hyperspectral Mapping
Published on: December 8, 2015
Monte Carlo simulations for dose enhancement in cancer treatment using bismuth oxide nanoparticles implanted in brain
Eslam Taha1, Fathi Djouider2, Essam Banoqitah2
1Nuclear Engineering Department, Faculty of Engineering, King Abdulaziz University, P. O. Box 80204, Jeddah, 21589, Saudi Arabia. eslam519@gmail.com.
Abstract:
The objective of this work is to study the dosimetric performances of bismuth oxide nanoparticles implanted in tumors in cancer radiotherapy. GEANT4 based Monte Carlo numerical simulations were performed to assess dose enhancement distributions in and around a 1 × 1 × 1 cm3 tumor implanted with different concentrations of bismuth oxide and irradiated with low energies 125I, 131Cs, and 103Pd radioactive sources. Dose contributions were considered from photoelectrons, Auger electrons, and characteristic X-rays. Our results show the dose enhancement increased with increasing both bismuth oxide concentration in the target and photon energy. A dose enhancement factor up to 18.55 was obtained for a concentration of 70 mg/g of bismuth oxide in the tumor when irradiated with 131Cs source. This study showed that bismuth oxide nanoparticles are innovative agents that could be potentially applicable to in vivo cancer radiotherapy due to the fact that they induce a highly localized energy deposition within the tumor.
Related Concept Videos
Treatment Resistant Cancers
Oxidation Numbers
Pyruvate Oxidation
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
Oxidation-Reduction Reactions
Dose Size and Dosing Frequency: Determination Methods
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

